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Introduction
Cardiac Magnetic Resonance (CMR) provides a compre-
hensive non-invasive characterization of acute myocardial
infarction (MI).
Purpose
to test whether a single CMR study may improve the prog-
nostic stratification of MI patients.
Methods
29 patients were studied on day 3 ± 1 after a first MI,
between June 2006 and April 2007. CMR included SSFP
and T2 STIR sequences, first pass perfusion, Early (EGE: 1
to 2 minutes) and Late (LGE: 10 to 15 minutes) Gadolin-
ium Enhancement. Subsequent clinical management was
not affected from CMR results, and patients underwent
the usual clinical and echocardiographic follow-up. In
2009 we tested the occurrence of the end-point of cardiac
death or left ventricular (LV) remodelling (EDVi > 90 ml/
m2 or LVEF < 50% at echocardiographic follow-up) in the
studied population.
Results
At 23 ± 5 months follow-up, the endpoint was observed
in 7 pts (25%): 1 cardiac death, 6 adverse LV remodeling.
See Table 1 for the prognostic role of different CMR
parameters: among the tested parameters, myocardial
haemorrhage, observed in 8 pts (27%), has a unique
96,5% accuracy in predicting the endpoint, with a 100%
NPV. Unexpectedly, LGE-based parameters such as total
infarct mass and the presence MVO show prognostic accu-
racy similar to the echocardiographic LVEF <50%. The 7
pts reaching the endpoint show both MVO (globally
present in 15 pts -51%-) and Myocardial Haemorrhage. It
seems that the assessment of MVO should keep in account
the total amount and not only the mere presence of MVO:
this hampers the usefulness of MVO, since the total
amount changes over time.
Conclusion
T2-STIR images allow a long-term prognostic stratification
of unrivalled accuracy during the acute phase of MI. The
use of gadolinium do not significantly improve the prog-
nostic accuracy of CMR.
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Positive Predictive Value % Negative Predictive Value % Accuracy %
LGE
(>20% LV mass)
13 (44%) 53,8 93,8 72.4
MVO (present) 15 (51%) 46.7 100 72.4
LVEF
(< 50%)
14 (48%) 50.0 100 75.9
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